Efficacy and Safety Study of Eprotirome in HeFH Patients Who Are on Optimal Standard of Care (AKKA)
This study has been terminated.
Sponsor:
Karo Bio AB
Information provided by (Responsible Party):
Karo Bio AB
ClinicalTrials.gov Identifier:
NCT01410383
First received: July 13, 2011
Last updated: August 31, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | October 2014 |
| Estimated Primary Completion Date: | October 2013 (Final data collection date for primary outcome measure) |